Status:
NOT_YET_RECRUITING
Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs
Lead Sponsor:
Qilu Hospital of Shandong University
Collaborating Sponsors:
China-Japan Friendship Hospital
The Affiliated Hospital of Qingdao University
Conditions:
Pancreatic Neuroendocine Neoplasms (pNETs)
Eligibility:
All Genders
18-85 years
Brief Summary
The aim of this observational multicenter retrospective cohort study is to evaluate the differences in risk factors, prognosis, clinicopathological and metabolic characteristics between early-onset pa...
Eligibility Criteria
Inclusion
- 18 years or older; histopathologically confirmed pancreatic neuroendocrine tumor by surgical resection or biopsy.
Exclusion
- Pancreatic neuroendocrine carcinoma; incomplete pathological data; received antitumor treatment prior to presentation; with other malignanies or malignant history.
Key Trial Info
Start Date :
August 31 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT07136701
Start Date
August 31 2025
End Date
July 31 2027
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, Shandong, China